ACAP Webinar: Thursday, July 24th | 2:00PM EST
As GLP-1 medications like Ozempic, Wegovy and Zepbound surge in popularity for treating diabetes and obesity, Medicaid programs across the U.S. are grappling with unprecedented financial and policy challenges. With patients paying upwards of $11,000 annually for a year supply, and Medicaid spending on these drugs skyrocketing from $577 million in 2019 to nearly $4 billion […]
read more >
July 9, 2025